The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic and outcome analysis of recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC) receiving systemic therapy: Results from the Australian MoST and CaSP screening programs.
 
Frank Lin
No Relationships to Disclose
 
David Goldstein
Honoraria - AstraZeneca; Boehringer Ingelheim; duo oncology; Merck; Sun Biopharma
Consulting or Advisory Role - amplicare; AstraZeneca; Boehringer Ingelheim; duo oncology; hC bioscience; Medison; MSD Oncology; Seagen; sun biopharma; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); pfizer (Inst); Zucero Therapeutics (Inst)
 
John Grady
No Relationships to Disclose
 
Christine Napier
Stock and Other Ownership Interests - Australian Clinical Laboratories; Telix Pharmaceuticals
 
Subotheni Thavaneswaran
Honoraria - The Limbic
Research Funding - AstraZeneca (Inst); Elevation Oncology (Inst); Roche/Genentech (Inst)
 
Omali Pitiyarachchi
No Relationships to Disclose
 
Maya Kansara
No Relationships to Disclose
 
Lorraine Chantrill
Honoraria - Amgen; Amgen; Eisai; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - BMS Australia; MSD Oncology
Research Funding - AstraZeneca (Inst)
 
Katrin Sjoquist
Honoraria - Astellas Pharma; Bayer (Inst); BMS; Glenmark (Inst); Lisata (Inst); MSD; Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
Keith Thornton
No Relationships to Disclose
 
Aparna Raina
No Relationships to Disclose
 
Astrid Magenau
No Relationships to Disclose
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Mandy Ballinger
Honoraria - Roche (I)
Research Funding - Amgen (I); AstraZeneca (I); Bayer (I); Elevation Oncology (I); George Clincal (I); Lilly (I); Microba (I); Pfizer (I); Roche (I); Seagen (I); Sun Pharma (I)
Travel, Accommodations, Expenses - Amgen (I)
 
George Sharbeen
No Relationships to Disclose
 
Paul Timpson
No Relationships to Disclose
 
Marina Pajic
No Relationships to Disclose
 
Phoebe Phillips
No Relationships to Disclose
 
David Thomas
Employment - Australian Unity; Omico
Honoraria - Roche
Research Funding - Amgen; AstraZeneca; Bayer; Elevation Oncology; George Clincal (Inst); InterVenn Biosciences; Lilly (Inst); Microba (Inst); Pfizer; Roche; Seagen (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Amgen